secwatch.observer — SEC 8-K summary
======================================

Issuer:     USBC, Inc. (USBC)
CIK:        0001074828
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001654954-24-008803
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Know Labs publishes peer-reviewed study showing 93.37% accuracy in non-invasive glycemic status classification
--------------------------------------------------------------------------------

- Study in Diabetes Technology & Therapeutics: RF sensor and ML algorithm classified glycemic status with 93.37% accuracy vs. venous blood glucose.
- 31 participants with prediabetes or Type 2 diabetes; 2,637 paired observations from OGTT and control sessions.
- Sensitivities: 96.63% for normoglycemic, 85.51% for hyperglycemic; no misclassification between hypo- and hyperglycemic extremes.
- CEO Ron Erickson: proof-of-concept for non-invasive screening device to help identify undiagnosed diabetes in underserved populations.
- Company maintains focus on FDA-cleared non-invasive CGM (KnowU); RoW screening product explored with partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1074828/000165495424008803/0001654954-24-008803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1074828/000165495424008803/knwn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-008803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer